Probe Set I Title Gene SymboMap LocatioGO bio procGO cell comGO molec fu 1000_at mitogen-activMAPK3 16p12-p11.2 GO:7165;signal transduct GO:4707;MA 1005_at dual specific DUSP1 5q34 GO:6979;oxidative stress GO:4726;non 1007_s_at 1008_f_at 1009_at histidine triadHINT1 5q31.2 GO:7165;sig GO:5856;cyt GO:5080;pro 101_at dual-specific DYRK4 12p13.33 GO:6468;protein phosphoGO:4672;pro 1011_s_at tyrosine 3-moYWHAE 17p13.3 GO:7242;intracellular signGO:5515;pro 1014_at polymerase (POLG 15q25 GO:6261;DNGO:5739;mitGO:3895;gam 1018_at wingless-typeWNT10B 12q13 GO:7165;signal transduction;not record 1019_g_at wingless-typeWNT10B 12q13 GO:7165;signal transduction;not record 1020_s_at calcium and CIB1 15q25.3-q26 GO:6302;double-strand b GO:5515;pro 1030_s_at topoisomerasTOP1 20q12-q13.1 GO:3917;DN 1031_at SFRS proteinSRPK1 6p21.3-p21.2GO:8380;RNGO:5634;nucGO:3750;cel 1034_at tissue inhibitoTIMP3 22q12.3 GO:6508;proteolysis and GO:8191;me 1035_g_at tissue inhibitoTIMP3 22q12.3 GO:6508;proteolysis and GO:8191;me 1038_s_at 1039_s_at hypoxia-induHIF1A 14q21-q24 GO:6950;stress response GO:3700;tra 1040_s_at abl-interacto ABI-2 2q33 GO:5070;SH 1044_s_at E2F transcripE2F5 8q21.13 GO:74;cell cycle control;p GO:5515;pro 1046_at retinoic acid-RI58 10q23.33 1048_at retinoid X recRXRG 1q22-q23 GO:4886;ret 1049_g_at retinoid X recRXRG 1q22-q23 GO:4886;ret 1050_at melan-A MLANA 9p24.1 GO:5887;inteGO:8222;tum 1051_g_at melan-A MLANA 9p24.1 GO:5887;inteGO:8222;tum 1052_s_at CCAAT/enhaCEBPD 8p11.2-p11.1GO:6366;transcription from Pol II prom 1053_at replication faRFC2 7q11.23 GO:5663;DNGO:3687;DN 1054_at replication faRFC4 3q27 GO:6271;DNGO:5663;DNGO:3687;DN 1055_g_at replication faRFC4 3q27 GO:6271;DNGO:5663;DNGO:3687;DN 1057_at 1058_at WAS protein WASF3 13q12 GO:6461;proGO:15629;acGO:8651;act 106_at runt-related tRUNX3 1p36 GO:6366;transcription fromGO:5524;AT 1064_at protein tyros PTK9 12p11.22 GO:6468;protein phosphoGO:4713;pro 1067_at fms-related t FLT3LG 19q13.3 GO:7165;sig GO:5625;sol GO:5102;liga 1070_at general transGTF2B 1p22-p21 GO:6366;transcription fromGO:16251;ge 1071_at GATA bindinGATA2 3q21 GO:6366;tra GO:5634;nucGO:3700;tra 1072_g_at GATA bindinGATA2 3q21 GO:6366;tra GO:5634;nucGO:3700;tra 1073_at transcription TCEA1 3p22-p21.3 GO:6357;transcription regGO:16251;ge 1074_at RAB1A, memRAB1A 2p14 GO:16192;vesicle transpoGO:3928;RA 1081_at 1085_s_at phospholipasPLCG2 16q24.1 GO:7166;cell surface receGO:4629;pho 109_at Rab9 effectoRAB9P40 9q34.11 GO:6898;recGO:5768;endGO:5482;ves 1093_at protein phos PPP2R1B 11q23 GO:8601;pro 1100_at interleukin-1 IRAK1 Xq28 GO:6952;defense responsGO:4704;NF 1101_at amyloid betaAPBB1 11p15 GO:7165;signal transduct GO:5208;am 1104_s_at 1105_s_at T cell receptoTRB 7q34 1106_s_at T cell receptoTRA 14q11.2 1107_s_at interferon-sti ISG15 1p36.33 111_at Rab geranylgRABGGTA 14q11.2 GO:6464;protein modifica GO:4663;RA 1113_at bone morphoBMP2 20p12 GO:1501;skeletal developGO:5102;liga 1114_at bone morphoBMP4 14q22-q23 GO:7498;mesoderm deveGO:4871;sig 1116_at CD19 antige CD19 16p11.2 GO:7166;cel GO:5887;inteGO:5057;rec 1119_at replication prRPA2 1p35 GO:6261;DNGO:5662;DNGO:3697;sin 1120_at glutathione SGSTM3 1p13.3 GO:8065;establishment o GO:4364;glu 1121_g_at glutathione SGSTM3 1p13.3 GO:8065;establishment o GO:4364;glu 1122_f_at 1126_s_at 1130_at mitogen-activMAP2K1 15q22.1-q22 GO:7165;signal transduct GO:4708;MA 1131_at mitogen-activMAP2K2 7q32 1133_at EN2 7q36 1134_at activated p21ACK1 3q29 GO:7010;cyt GO:5737;cyt GO:4715;non 1135_at G protein-co GPRK5 10q24-qter GO:7188;G-pGO:5737;cyt GO:4678;G-p 1136_at deoxythymid DTYMK 2 GO:6259;DNA metabolismGO:4798;thy 1138_at solute carrierSLC20A1 2q11-q14 GO:6832;smGO:5887;inteGO:4872;rec 1140_at integrin, alphITGAE 17p13 GO:7159;leuGO:8305;inteGO:4895;cel 1141_at 1147_at 1148_s_at 1150_at 1151_at 1154_at eukaryotic traEIF2S1 14q23.3 GO:5844;polGO:3743;tra 1158_s_at calmodulin 3 CALM3 19q13.2-q13.3 GO:5509;cal 1160_at 1161_at 1162_g_at 1164_at 1166_at proteasome PSMD2 3q27.3 GO:5837;26S proteasome 1170_at 1173_g_at 1177_at 1178_at 1179_at 1180_g_at 1184_at proteasome PSME2 14q11.2 GO:5837;26S proteasome 1189_at cyclin-depen CDK8 13q12 GO:74;cell cycle control;p GO:3750;cel 1191_s_at proteasome PSMD11 17q11.2 GO:5837;26S proteasome 1192_at proteasome PSMD12 17q24.2 GO:5837;26S proteasome 1195_s_at integrin cytopICAP-1A 2p25.2 GO:7155;cel GO:157;peripGO:4895;cel 1196_at 1197_at 1198_at 1199_at eukaryotic traEIF4A1 17p13 GO:6441;mRGO:8304;eukGO:3729;mR 120_at integrin, alphITGA1 5q11.1 1201_at RAB33A, meRAB33A Xq26.1 GO:3928;RA 1202_g_at RAB33A, meRAB33A Xq26.1 GO:3928;RA 1206_at cyclin-depen CDK5 7q36 GO:8283;cell proliferation GO:3750;cel 121_at paired box gePAX8 2q12-q14 GO:7397;histogenesis andGO:4996;thy 1211_s_at CASP2 and CRADD 12q21.33-q2 GO:8625;induction of apo GO:5037;dea 1212_at glutathione trGSTZ1 14q24.3 GO:6559;phenylalanine caGO:4602;glu 1213_at SFRS proteinSRPK2 7q22-q31.1 GO:245;splicGO:5634;nucGO:4672;pro 1216_at 1217_g_at protein kinasPRKCB1 16p11.2 GO:7165;sig GO:5737;cyt GO:4697;pro 1218_at 1224_at PCTAIRE proPCTK1 Xp11.3-p11.2GO:74;cell cycle control;p GO:4674;pro 1225_g_at PCTAIRE proPCTK1 Xp11.3-p11.2GO:74;cell cycle control;p GO:4674;pro 1226_at a disintegrin ADAM17 2p25 GO:7267;cel GO:157;peripGO:8237;me 1228_s_at meningioma MGEA6 14q GO:5515;pro 1230_g_at cisplatin resisCRA 1q12-q21 1235_at tyrosine 3-moYWHAZ 8q23.1 GO:5515;pro 1237_at immediate eaIER3 6p21.3 GO:6916;anti-apoptosis;p GO:8189;apo 1238_at mitogen-activMAPK9 5q35 GO:7165;signal transduct GO:4705;JU 1240_at caspase 2, aCASP2 7q34-q35 GO:8632;apoptotic prograGO:4202;cas 1241_at protein tyros PTP4A2 1p35 GO:4725;pro 1242_at Ets2 repress ERF 19q13 GO:6357;transcription regGO:8181;tum 1243_at damage-spe DDB2 11p12-p11 GO:6281;DNA repair;expeGO:3684;dam 1244_at 1248_at polymerase (POLR2H 3q28 GO:6366;tra GO:5665;DNA-directed R 125_r_at 1250_at protein kinasPRKDC 8q11 GO:6464;protein modifica GO:4672;pro 1251_g_at RAP1, GTPaRAP1GA1 1p36.1-p35 GO:7165;signal transduct GO:5096;GT 1252_at DNA segmenD5S346 5q22-q23 GO:9626;hypersensitive response;pred 1253_at glycogen synGSK3B 3q13.3 GO:5977;glycogen metab GO:4696;gly 1257_s_at quiescin Q6 QSCN6 1q24 GO:74;cell cycle control;predicted/com 1258_s_at 126_s_at synovial sarcSSX2 Xp11.23-p11.22 1265_g_at protein tyros PTPN2 18p11.3-p11 GO:6470;protein dephospGO:4725;pro 1268_at ubiquitin-acti UBE1 Xp11.23 GO:6260;DNA replication GO:4839;ubi 1269_at phosphoinosPIK3R1 5q12-q13 1270_at RAP1, GTPaRAP1GA1 1p36.1-p35 GO:7165;signal transduct GO:5096;GT 1271_g_at v-rel reticuloeRELA 11q13 GO:6366;tra GO:5667;tra GO:5515;pro 1272_at eukaryotic traEIF2S3 Xp22.2-p22.1 GO:5850;eukGO:8135;tra 1274_s_at cell division cCDC34 19p13.3 GO:76;DNA replication chGO:4840;ubi 1278_at 1284_at 1287_at ADP-ribosylt ADPRT 1q41-q42 GO:6471;proGO:5634;nucGO:3677;DN 1288_s_at 1294_at ubiquitin-acti UBE1L 3p21 GO:6464;protein modifica GO:4840;ubi 1295_at v-rel reticuloeRELA 11q13 GO:6366;tra GO:5667;tra GO:5515;pro 1296_at cadherin 15, CDH15 16q24.3 GO:7155;cel GO:5886;plaGO:5194;cel 1300_at X-ray repair cXRCC2 7q36.1 GO:7126;meiosis;predicted/computed G 1302_s_at 1306_at eukaryotic traEIF4G1 3q27-qter GO:6445;tra GO:8304;eukGO:8135;tra 1307_at xeroderma p XPA 9q22.3 GO:6281;DNGO:5634;nucGO:3685;DN 1308_g_at xeroderma p XPA 9q22.3 GO:6281;DNGO:5634;nucGO:3685;DN 1309_at proteasome PSMB3 17q12 GO:5837;26S proteasome 131_at TAF11 RNA TAF11 6p21.2 GO:5669;TF GO:5515;pro 1310_at proteasome PSMB2 1p34.2 GO:5837;26S proteasome 1311_at proteasome PSMB4 1q21 GO:5837;26S proteasome 1312_at proteasome PSMD8 19q13.13 GO:74;cell cyGO:5838;19S proteasome 1313_at proteasome PSMB7 9q34.11-q34.12 GO:5837;26S proteasome 1314_at proteasome PSMD1 2q36.1 GO:5837;26S proteasome 1315_at 1316_at thyroid horm THRA 17q11.2 GO:6366;tra GO:5634;nucGO:3700;tra 1318_at retinoblastomRBBP4 1p34.3 GO:8285;negGO:5634;nucleus;experim 1319_at discoidin domDDR2 1q12-q23 GO:7155;cel GO:5887;inteGO:4714;tra 1323_at 1325_at MAD, mothe MADH1 4q28 1326_at caspase 10, CASP10 2q33-q34 GO:6917;induction of apo GO:4206;cas 1327_s_at mitogen-activMAP3K5 6q22.33 GO:7257;activation of JUNGO:4709;MA 133_at cathepsin C CTSC 11q14.1-q14 GO:6508;proGO:5764;lysosome;not re 1336_s_at protein kinasPRKCB1 16p11.2 GO:7165;sig GO:5737;cyt GO:4697;pro 1342_g_at telomeric repTERF1 8q13 GO:7088;conGO:5696;telomere;experim 1347_at cell division cCDC25B 20p13 GO:74;cell cycle control;p GO:4725;pro 1348_s_at propionyl Co PCCA 13q32 GO:6631;fattGO:5739;mitGO:4658;pro 1351_at EphB4 EPHB4 7q22 GO:7397;his GO:5887;inteGO:4714;tra 1356_at death associ DAP3 1q21-q22 GO:8624;induction of apoptosis by extr 1357_at ubiquitin spe USP4 3p21.3 GO:6514;deuGO:5737;cyt GO:4843;ubi 1361_at telomeric repTERF1 8q13 GO:7088;conGO:5696;telomere;experim 1362_s_at retinoid X recRXRB 6p21.3 GO:5634;nucGO:3713;tra 1363_at fibroblast groFGFR2 10q26 1364_at protein tyros PTPRZ1 7q31.3 GO:7417;cenGO:5887;inteGO:5001;tra 1366_i_at ubiquitin C UBC 12q24.3 GO:5552;pol 1367_f_at ubiquitin C UBC 12q24.3 GO:5552;pol 1368_at interleukin 1 IL1R1 2q12 GO:7166;cel GO:5887;inteGO:4908;inte 1370_at interleukin 7 IL7R 5p13 GO:7166;cell surface receGO:4917;inte 1372_at tumor necrosTNFAIP6 2q23.3 GO:7267;cel GO:5576;extGO:4895;cel 1373_at transcription TCF3 19p13.3 GO:6955;immune responsGO:3702;RN 1375_s_at tissue inhibitoTIMP2 17q25 GO:8191;me 1377_at nuclear factoNFKB1 4q24 GO:6954;infl GO:5634;nucGO:3700;tra 1378_g_at nuclear factoNFKB1 4q24 GO:6954;infl GO:5634;nucGO:3700;tra 1379_at EphA2 EPHA2 1p36 GO:7275;devGO:5887;inteGO:4714;tra 1382_at replication prRPA1 17p13.3 GO:6310;DNGO:5662;DNGO:3697;sin